Physician profile
John K Everett
NPI 1881628253
$615.74
in general payments reported to CMS, 2019-2025
8 companies · $75.70 in 2025
The $75.70 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $11.02 · 2021: $83.63 · 2022: $53.68 · 2023: $173 · 2024: $36.15 · 2025: $75.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $219.37 | 2019-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $100.71 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $94.22 | 2019-2020 | |
| Amgen INC. | $68.15 | 2024-2025 | Krystexxa |
| Exact Sciences Corporation | $41.62 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $36.60 | 2022 | |
| Janssen Pharmaceuticals, INC | $30.90 | 2019 | |
| Axsome Therapeutics, INC. | $24.17 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Everett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.